ATYR PHARMA INC : RBC ADJUSTS TARGET PRICE TO $6 FROM $40 TO REFLECT 1-FOR-40 REVERSE STOCK SPLIT

Reuters2026/11/06 05:44

By:Reuters

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Riot Platforms (RIOT) Stock Price Prediction 2026, 2027, 2030 – 2040: How High Can RIOT Stock Go?

Coinpedia•2026/11/10 15:36

AI Chip Stocks are Cheapest in 15 Years. Is the Sell-Off Over?

BeInCrypto•2026/11/10 14:48

TELEVISA <TLEVISACPO.MX>: UBS CUTS TARGET PRICE TO MXN 8.7 FROM MXN 11.2

Reuters•2026/11/10 13:13

VIVMARK RESIDENTIAL <VMRK.N>: UBS RAISES TARGET PRICE TO $74 FROM $71

Reuters•2026/11/10 13:13